Investing

Esperion Therapeutics : ESPR

ESPR

Stock Data

$4.06

$0.23 (5.87%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Esperion Therapeutics is a pharmaceutical company focused on creating medicines to help patients manage elevated low density lipoprotein cholesterol, a key factor in heart disease. Its main products, NEXLETOL and NEXLIZET, are designed for individuals with cardiovascular issues or specific genetic cholesterol conditions. Based in Ann Arbor, Michigan, and founded in 2008, Esperion also collaborates with other firms to expand its portfolio, including working on an innovative oral treatment for cholesterol management.

All Esperion Therapeutics Articles

10 Articles

Lee Jackson | Feb 27, 2023 at 8:49 AM EST

Monday’s Top Analysts Upgrades and Downgrades: Block, Broadcom, CarMax, Deere, Marvell Technology, MGM Resorts, Moderna, Newmont and More

Monday's top analyst upgrades and downgrades included Block, Broadcom, CarMax, Deere, Esperion Therapeutics, Marvell Technology, MGM Resorts International, Moderna, Newmont,…

Chris Lange | Aug 3, 2022 at 11:45 AM EDT

Will July’s Employment Report Make or Break? Analysts Upgrade or Downgrade PayPal, XPeng and More

Wednesday's additional top analyst upgrades and downgrades included CF Industries, Cognex, Incyte, PayPal, XPeng and Xylem.

Lee Jackson | Dec 6, 2021 at 8:53 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Monday’s top analyst upgrades and downgrades included Amgen, Apple, AT&T, Chevron, Dollar General, Fastly, Ford, Hertz, Kroger, Marvell Technology, Peloton…

Chris Lange | Oct 19, 2021 at 3:18 PM EDT

Tuesday Afternoon Analyst Upgrades and Downgrades: CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and More

Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.

Lee Jackson | May 5, 2021 at 8:53 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Clorox, Conoco, Exxon, Kraft Heinz, Nvidia, Under Armour and More

Wednesday's top analyst upgrades and downgrades included Clorox, ConocoPhillips, Exxon Mobil, Ferrari, Kraft Heinz, Nvidia and Under Armour.

Chris Lange | Apr 26, 2021 at 11:46 AM EDT

Alexion, Activision, Baker Hughes and More Monday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma,…

Chris Lange | Mar 11, 2021 at 12:14 PM EST

AEP, Oracle, Tesla and More Thursday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including American Electric…

Lee Jackson | Feb 9, 2021 at 8:56 AM EST

Top Analyst Upgrades and Downgrades: Bilibili, Constellation Brands, FedEx, Harley-Davidson, Matador Resources, Twilio, Yandex and More

Tuesday's top analyst upgrades and downgrades included Bilibili, Constellation Brands, FedEx, Harley-Davidson, Matador Resources, Twilio and Yandex.

Jon C. Ogg | Aug 11, 2020 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, Booking, Carvana, EA, EOG, Honeywell, ICE, Livongo, Nucor, Seres, Sunrun and More

Tuesday's top analyst upgrades and downgrades included Bed Bath & Beyond, Booking, Carvana, Electronic Arts, EOG Resources, Honeywell, Intercontinental Exchange,…

Jon C. Ogg | Sep 16, 2019 at 9:01 AM EDT

Top Analyst Upgrades and Downgrades: Aimmune, Apple, Aurora Cannabis, Dick’s, Halliburton, HP, JPMorgan, Lowe’s, Lyft, Schlumberger, Uber and More

The top analyst upgrades, downgrades and initiations for Monday included Aimmune Therapeutics, Apple, Aurora Cannabis, Dick's Sporting Goods, Halliburton, HP,…